Shares of Novavax Inc. NVAX, -1.64% shed 1.64% to $9.01 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +1.59% rising 1.59% to 13,721.03 and the Dow Jones Industrial Average DJIA, +0.54% rising 0.54% to 34,472.98.
The stock’s fall snapped a two-day winning streak.
Novavax Inc. closed $28.90 short of its 52-week high ($37.91), which the company achieved on August 24th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ, -0.90% fell 0.90% to $164.53, Pfizer Inc. PFE, -0.49% fell 0.49% to $36.66, and Merck & Co. Inc. MRK, +3.80% rose 3.80% to $111.30.
Trading volume (12.8 M) eclipsed its 50-day average volume of 7.5 M.